Cardio Diagnostics Holdings, Inc.
CDIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -61.8% | 695.2% | -79.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -3,037.9% | -1,092.5% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $2 | $1 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -59,950.9% | -22,457.5% | -173,463.8% | -33,608.2% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$2 | -$2 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -60,053.8% | -22,517.7% | -173,943% | -33,672.6% |
| EPS | -0.98 | -0.97 | -0.97 | -0.062 |
| % Growth | -1% | 0% | -1,459.5% | – |
| EPS Diluted | -0.98 | -0.97 | -0.97 | -0.062 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 46 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 46 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$2 | -$1 |
| % Margin | -56,806.3% | -21,262.4% | -160,112% | -31,733.4% |